Early detection of immunogenicity reactions is a key component of a drug development programme.
This essential 2-day course shows you how to detect, reduce and characterise unwanted immunogenicity, interpret the last US and EU regulatory guidelines and formulate a winning strategy that you can implement into your business immediately.
Critical steps to detect and characterise unwanted immunogenicity
• Review the fundamentals of immunogenicity
• Understand why proteins can be immunogenic and why immunogenic testing is necessary for your products
• Consider the various methods and formats used to detect unwanted immunogenicity – how they compare and when to employ them
• Learn how to develop, standardize and validate your assays to improve accuracy and robustness
• Apply theoretical knowledge by executing 3 hands-on exercise during the course
• Appreciate and overcome the critical issues in assay validation using real-life examples
• Develop an appropriate risk strategy for your immunogenicity program
• Interpret and implement the latest EMA, FDA and industry documents
Those working in:
• Biotech R&D Staff
• Bioanalytical Scientists
• Clinical Research Associates
• Validation Specialists
• Project Management
• Regulatory Affairs
• QA/QC
Follow PTI on twitter:
@PTI_Courses

Connect with the PTI faculty! PTI is a global pharmaceutical training company with over 60 interctive courses focusing on Regulatory Affairs, R&D, Clinical, Business Strategy, Fine Chemicals, Biopharmaceuticals, Manufacturing, Medical Devices and Agrochemicals